Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge

Folia Histochemica et Cytobiologica

Volumn 48, Issue 4, 2010, Pages 518-523

  Kowal, Krzysztof ^a   Moniuszko, Marcin ^a   Zukowski, Sebastian ^a   Bodzenta Lukaszyk, Anna ^a  

^a Department of Allergology and Internal Medicine ^*  (Poland)

Author keywords

Allergen challenge; Asthma; Plasminogen activator inhibitor; Urokinase

Indexed keywords

ALLERGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; UROKINASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; ENZYME IMMUNOASSAY; FEMALE; HOUSE DUST ALLERGY; HUMAN; INHALATION TEST; MALE; SPUTUM LEVEL;

DERMATOPHAGOIDES PTERONYSSINUS; PYROGLYPHIDAE;

EID: 79958054263     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.2478/v10042-010-0075-2     Document Type: Article

References (28)

1. Busse W, Elias J, Sheppard D, Banks-Schelegel A. Airway remodeling and repair. Am J Respir Crit Care Med. 1999;160:1035-42.
2. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airway remodeling is a distinctive feature of asthma and is related to severity of asthma. Chest. 1997;111:852-7.
3. Global Strategy for Asthma Management and Prevention. NIH publication No 02-365P. Revised 2002.
4. Johnson JR, Wiley RE, Fattouh R et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med. 2004;169:378-85.
5. Kucharewicz I, Kowal K, Buczko W, Bodzenta-Lukaszyk A. The plasmin system in airway remodeling. Thromb Res. 2003;112:1-7.
6. Ma Z, Paek D, Oh CK. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin Exp Allergy. 2009;39:1136-44.
7. Sejima T, Madoiwa S, Mimuro J, Sugo T, Okada K, Ueshima S et al. Protection of plasminogen activator inhibitor-1-deficient mice from nasal allergy. J Immunol. 2005;174:8135-43.
8. Oh CK, Ariue B, Alban RF, Shaw B, Cho SH. PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun. 2002;294:1155-60.
9. Kuramoto E, Nishiuma T, Kobayashi K, Yamamoto M, Kono Y, Funada Y, Kotani Y et al. Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. Am J Physiol Lung Cell Mol Physiol. 2009;296:L337-46.
10. Begin P, Tremblay K, Daley D, Lamire M, Claveau S et al. Association of urokinase-type plasminogen activator with asthma and atopy. Am J Respr Crit Care Med. 2007;175:1109-16.
11. Cho SH, Hall IP, Wheatley A, Dewar J, Abraha D, Del Mundo J et al. Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. J Allergy Clin Immunol. 2001;108:212-14.
12. Buckova D, Izakovicova Holla L, Vacha J. Polymorphism 4G/5G in the Plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy. 2002;57:446-8.
13. Pampuch A. Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy. 2006;61:234-8.
14. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S, Donati MB, Iacoviello L. Analysis of -675 4G/5G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients. J Investig Allergol Clin Immunol. 2008;18:284-92.
15. Ozbek OY, Atac FB, Ogus E, Ozbek N. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis. Allergy Asthma Proc. 2009;30:41-6.
16. Kowal K, Zukowski S, Moniuszko M, Bodzenta-Lukaszyk A. Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients. Folia Histochem Cytobiol. 2008;46:193-8.
17. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Donati MB, Iacoviello L. Plasminogen activator inhibitor-1 (PAI-1) plasma concentration in allergic asthma patients during allergen challenge. Int Arch Allergy Immunol. 2007;144:240-6.
18. Kowal K, Osada J, Zukowski S, Dabrowska M, DuBuske LM, Bodzenta-Lukaszyk A. Expression of interleukin-4 receptor in bronchial asthma patients treated with specific immunotherapy (SIT). Ann Allergy Asthma Immunol. 2004;93:68-75.
19. Kowal K, Moller HJ, DuBuske LM, Moestrup SK, Bodzenta- Lukaszyk A. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergeninduced bronchoconstriction. Clin Exp Allergy. 2006;36:1584-91.
20. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996;97:232-7.
21. Kucharewicz I, Mogielnicki A, Kasacka I, Buczko W, Bodzenta-Lukaszyk A. Plasmin system regulation in an ovalbumin- induced rat model of asthma. Int Arch Allergy Immunol. 2008;147:190-6.
22. Kelly MM, Leigh R, Bonniaud P, Ellis R, Wattie J, Smith MJ et al. Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling. Am J Respir Cell Mol Biol. 2005;32:99-107.
23. Cho SH, Tam SW, Demissie-Sanders S, Filler SA, Oh CK. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol. 2000;165:3154-61.
24. Gunderson D, Tran-Thang C, Sordat B, Mourali F, Ruegg C. Plasmin induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J Immunol. 1997;158:1051-60.
25. Shetty S, Bdeir K, Cines DB, Idell S. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem. 2003;278:18124-31.
26. Marshall BC, Xu QP, Rao NV, Brown BR, Hoidal JR. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1ß and tumor necrosis factor-α.
27. Chu EK, Cheng J, Foley JS, Mecham BH, Owen CA, Haley KJ, et al. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2006;35:628-38.
28. Ciao W, Hsu YP, Ishizaka A, Kirikae, Moss RB. Sputum cathelicidin, urokinase plasminogen system components and cytokine discriminate cystic fibrosis, COPD and asthma inflammation. Chest. 2005;128:2316-26.